LATISSE® (bimatoprost ophthalmic solution 0.03%), was approved by the FDA in 2008 as treatment for hypotrichosis of the eyelashes.
Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE® is the first and only FDA-approved, science-based treatment to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.
LATISSE® is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator.
LATISSE® users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks.
To maintain effect, continued treatment with LATISSE® is required. If use of LATISSE® is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).
If you’re not happy with the lashes you were born with LATISSE® is a great option that delivers real results. Latisse treatments are performed in our Lake Mary office by Dr. James Shoukas.